NMPA Approval

Human Papillomavirus (Types 16,18) Vaccine, Adsorbed

Approval Number

国药准字SJ20160027

CompanyGlaxoSmithKline Biologicals SA

Registration Date

August 10, 2021

Previous Approval Numbers

S20160027

Drug Information

Generic Name

双价人乳头瘤病毒吸附疫苗

Trade Name

希瑞适

Dosage Form

注射剂

Strength

100瓶/盒（小瓶包装）

Drug Type

生物制品

Registration Date

August 10, 2021

Expiry Date

August 9, 2026

Company Information

Applicant Company

Company NameGlaxoSmithKline Biologicals SA

Manufacturing Company

Company NameGlaxoSmithKline Biologicals SA

Company Address

Parc de la Noire Epine, Rue Fleming 20, Wavre 1300, Belgium

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

双价人乳头瘤病毒吸附疫苗 - NMPA 批准文号 | MedPath